Quoin Pharmaceuticals Statistics

Total Valuation

QNRX has a market cap or net worth of $5.72 million. The enterprise value is -$3.06 million.

Market Cap	5.72M
Enterprise Value	-3.06M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

QNRX has 588,166 shares outstanding. The number of shares has increased by 633.25% in one year.

Current Share Class	n/a
Shares Outstanding	588,166
Shares Change (YoY)	+633.25%
Shares Change (QoQ)	+213.72%
Owned by Insiders (%)	7.08%
Owned by Institutions (%)	1.84%
Float	515,649

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.97
P/TBV Ratio	1.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.47.

Current Ratio	2.57
Quick Ratio	2.38
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -138.82% and return on invested capital (ROIC) is -65.02%.

Return on Equity (ROE)	-138.82%
Return on Assets (ROA)	-47.40%
Return on Invested Capital (ROIC)	-65.02%
Return on Capital Employed (ROCE)	-136.15%
Revenue Per Employee	n/a
Profits Per Employee	-$2.09M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.89% in the last 52 weeks. The beta is 1.78, so QNRX's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	-52.89%
50-Day Moving Average	7.69
200-Day Moving Average	15.25
Relative Strength Index (RSI)	68.31
Average Volume (20 Days)	13,405

Short Selling Information

Short Interest	34,696
Short Previous Month	52,182
Short % of Shares Out	5.90%
Short % of Float	6.73%
Short Ratio (days to cover)	0.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.03M
Pretax Income	-8.28M
Net Income	-10.45M
EBITDA	-10.93M
EBIT	-11.03M
Earnings Per Share (EPS)	-$39.35

Full Income Statement

Balance Sheet

The company has $11.55 million in cash and $2.77 million in debt, giving a net cash position of $8.78 million or $14.93 per share.

Cash & Cash Equivalents	11.55M
Total Debt	2.77M
Net Cash	8.78M
Net Cash Per Share	$14.93
Equity (Book Value)	5.93M
Book Value Per Share	10.08
Working Capital	7.64M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-9.02M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-633.25%
Shareholder Yield	-633.25%
Earnings Yield	-182.56%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 0.0285714:1.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	0.0285714:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2